ENTRY       D11235                      Drug
NAME        Landogrozumab (USAN/INN)
FORMULA     C6338H9790N1694O1988S42
EXACT_MASS  142784.5317
MOL_WEIGHT  142872.4362
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGLTFS RYPMSWVRQA PGKGLVWVSA ITSSGGSTYY
            SDTVKGRFTI SRDNAKNTLY LQMNSLRAED TAVYYCARLP DYWGQGTLVT VSSASTKGPS
            VFPLAPCSRS TSESTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS
            VVTVPSSSLG TKTYTCNVDH KPSNTKVDKR VESKYGPPCP PCPAPEFLGG PSVFLFPPKP
            KDTLMISRTP EVTCVVVDVS QEDPEVQFNW YVDGVEVHNA KTKPREEQFN STYRVVSVLT
            VLHQDWLNGK EYKCKVSNKG LPSSIEKTIS KAKGQPREPQ VYTLPPSQEE MTKNQVSLTC
            LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SRLTVDKSRW QEGNVFSCSV
            MHEALHNHYT QKSLSLSLG
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASSSVS SSYLHWYQQK PGQAPRLLIY STSNLVAGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ HHSGYHFTFG GGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H127-L215, H140-H196, H219-H'219, H222-H'222, H254-H314, H360-H418, H'22-H'96, H'127-L'215, H'140-H'196, H'254-H'314, H'360-H'418, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Myostatin inhibitor
  TYPE      Monoclonal antibody
COMMENT     Treatment of muscle wasting disorders
TARGET      MSTN [HSA:2660] [KO:K05497]
  PATHWAY   hsa04060(2660)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Transforming growth factors (RSTK-binding)
                MSTN
                 D11235  Landogrozumab (USAN/INN)
DBLINKS     CAS: 1391726-30-9
            PubChem: 384585213
///
